A detailed history of Cva Family Office, LLC transactions in Genmab A/S stock. As of the latest transaction made, Cva Family Office, LLC holds 56 shares of GMAB stock, worth $1,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56
Previous 130 56.92%
Holding current value
$1,081
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025

SELL
$18.69 - $24.14 $1,383 - $1,786
-74 Reduced 56.92%
56 $1,000
Q4 2024

Jan 07, 2025

BUY
$20.02 - $24.15 $2,602 - $3,139
130 New
130 $2,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $12.7B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.